The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. AbCellera Biologics Inc’s current trading price is -43.24% away from its 52-week high, while its distance from the 52-week low is 22.18%. The stock’s price range for this period has been between $1.89 and $4.07 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.96 million for the day, a number notably higher than the average daily volume of 4.04 million over the last three months.
AbCellera Biologics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $4.07 on 06/04/24, while the lowest price for the same period was registered at $1.89 on 04/07/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
AbCellera Biologics Inc (ABCL) has experienced a quarterly decline of -1.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 689.50M and boasts a workforce of 596 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.57, with a change in price of -0.97. Similarly, AbCellera Biologics Inc recorded 4,150,831 in trading volume during the last 100 days, posting a change of -29.57%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
ABCL Stock Stochastic Average
AbCellera Biologics Inc’s raw stochastic average for the past 50 days is presently 53.16%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 92.50%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 49.70% and 29.14%, respectively.
ABCL Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -21.16%. However, over the last six months, the performance has been stronger by -23.00%. The price of ABCL decreased -4.15% over the last 30 days. And in the last five days, it has surged by 16.67%.
